Nov 20, 2019
New Report Reveals Major Gaps in Quality of Care for Canadians with Rare Lung Disease
Nov 15, 2019
Promedior Enters Into Definitive Merger Agreement To Be Acquired By Roche
Nov 04, 2019
NIH Awards Major Grant In Pulmonary Fibrosis Research
Oct 21, 2019
Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965
Oct 15, 2019
Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis
Oct 10, 2019
FDA Grants Ofev® Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
May 20, 2019
Promedior Announces Positive Long-term Safety and Efficacy Data from Open Label Extension Study of PRM-151 in Idiopathic Pulmonary Fibrosis
May 19, 2019
Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis
Apr 09, 2019
Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis
Feb 27, 2019
Biotechnology Companies Ramp up Funding as Deadly Diseases Come Into the Spotlight
Dec 16, 2018
Bridge Biotherapeutics Announces FDA Clearance of IND for its BBT-877, an Autotaxin Inhibitor for IPF
Nov 18, 2018
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis
Sep 17, 2018
Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases
Sep 17, 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Aug 22, 2018
Bridge Biotherapeutics Presented Preclinical Study Results on BBT-877, an Autotaxin inhibitor at the IPF Summit 2018
Aug 06, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
May 22, 2018
Prometic presents new clinical data on PBI-4050 for the treatment of idiopathic pulmonary fibrosis
May 22, 2018
Pliant Therapeutics Presents Idiopathic Pulmonary Fibrosis Biomarker Discovery Research at American Thoracic Society 2018 International Conference
Mar 28, 2018
Boehringer Ingelheim and Minor League Baseball Team Up to Raise Awareness of Rare Lung Disease - IPF
Mar 13, 2018
HGE Health Extends Its Telemedicine Technology Successes From One Disease To Another